Click Decline to reject or Customize to make more detailed advertising choices or learn about how to change your choices.
Formal analysis: AA, BA, PS, LA
Participants were adults with: Obesity (BMI 30 kg/m) or Overweight (BMI 27 kg/m) with at least one weight-related comorbidity such as hypertension, dyslipidemia, obstructive sleep apnea, or cardiovascular disease No diabetes diagnosis Participants were randomized 1:1 to receive either: Maximum tolerated dose of Zepbound (10 mg or 15 mg) Maximum tolerated dose of Wegovy (1.7 mg or 2.4 mg) The study cohort had a mean age of 44.7 years, 64.7% were women, and participants had an average body weight of 249 pounds with a mean BMI of 39.4 kg/m
The most common mistake is assuming all NAD+ works the same regardless of how its delivered
Participants also showed improvements in several key health markers, including reduced systolic blood pressure, triglycerides and non-HDL cholesterol
Pre-meal: Consuming 5-10 grams of fiber 15 minutes before meals significantly reduces post-meal blood sugar spikes